Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: A multicenter registry

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Catheterization and cardiovascular interventions

• Publication date

  2017-02-15

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1002/ccd.26782PMID 27651124
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug.

  2016cited by this paper
• Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial.

  2016influential reference
• Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry

  2016cited by this paper
• EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion.

  2015cited by this paper
• Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.

  2014influential reference
• The management of atrial fibrillation: summary of updated NICE guidance

  2014cited by this paper
• EHRA / EAPCI expert consensus statement on catheter-based left atrial appendage occlusion

  2014cited by this paper
• Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

  2014cited by this paper
• Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).

  2013cited by this paper
• 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.

  2012cited by this paper
• 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

  2012cited by this paper
• Apixaban versus Warfarin in Patients with Atrial Fibrillation

  2012cited by this paper
• Apixaban versus warfarin in patients with atrial fibrillation.

  2011cited by this paper
• Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

  2011cited by this paper
• Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.

  2011cited by this paper
• Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry

  2011cited by this paper
• Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

  2010cited by this paper
• Dabigatran versus warfarin in patients with atrial fibrillation.

  2009cited by this paper
• Dabigatran versus warfarin in patients with atrial fibrillation.

  2009cited by this paper
• Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin

  2004cited by this paper
• Hemorrhagic complications of anticoagulant treatment.

  2001cited by this paper
• Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

  2001cited by this paper
• Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation

  2001cited by this paper
• Why do patients with atrial fibrillation not receive warfarin?

  2000cited by this paper
• Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.

  1996cited by this paper
• Hemorrhagic complications of anticoagulant treatment.

  1992cited by this paper

• Left atrial appendage occlusion in patients with cancer

  2025cites this paper
• Left atrial appendage occlusion in patients with atrial fibrillation and intracerebral haemorrhage associated with cerebral amyloid angiopathy: a multicentre observational study and pooled analysis of published studies

  2024cites this paper
• Percutaneous Left Atrial Appendage Closure: Review of Anatomy, Imaging, and Outcomes

  2022cites this paper
• Left atrial appendage occlusion in the UK: prospective registry and data linkage to Hospital Episode Statistics

  2021cites this paper
• Una década de cierre percutáneo de la orejuela izquierda: desde el procedimiento hasta el beneficio a largo plazo

  2021cites this paper
• A decade of left atrial appendage closure: from procedural data to long-term clinical benefit

  2021cites this paper
• Clinical follow-up of left atrial appendage occlusion in patients with atrial fibrillation ineligible of oral anticoagulation treatment—a systematic review and meta-analysis

  2021cites this paper
• Thoracoscopic surgical ablation versus catheter ablation as first-line treatment for long-standing persistent atrial fibrillation: the CASA-AF RCT

  2021cites this paper
• Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience

  2021cites this paper
• Short-Term Antiplatelet Versus Anticoagulant Therapy After Left Atrial Appendage Occlusion: A Systematic Review and Meta-Analysis.

  2020cites this paper
• EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update.

  2020cites this paper
• Observed versus Expected Ischemic and Bleeding Events Following Left Atrial Appendage Occlusion.

  2020cites this paper
• Late discovery of left atrial appendage occluder device embolization: a case report

  2020cites this paper
• Percutaneous Left Atrial Appendage Occlusion: A View From the UK

  2020cites this paper
• Endocardial versus epicardial left atrial appendage exclusion for stroke prevention in patients with atrial fibrillation: Midterm follow‐up

  2020cites this paper
• Novel Devices for Stroke Prevention

  2020cites this paper
• Devices for continuous embolic protection

  2020cites this paper
• Current Endocardial Approaches for Left Atrial Appendage Closure

  2019cites this paper
• Long-term Outcomes Following Left Atrial Appendage Closure: Gaining Perspective on Non-pharmacological Stroke Prevention in Atrial Fibrillation.

  2019cites this paper
• Percutaneous devices for left atrial appendage occlusion: A contemporary review

  2019cites this paper
• Resultados a largo plazo tras el cierre de la orejuela izquierda: ampliando la perspectiva en la prevención no farmacológica del ictus en pacientes con fibrilación auricular

  2019cites this paper
• EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update.

  2019cites this paper
• Long‐term clinical outcomes from real‐world experience of left atrial appendage exclusion with LARIAT device

  2019cites this paper
• Left atrial appendage occlusion: a critical appraisal updated with recent evidence.

  2019cites this paper
• Left Atrial Appendage Occlusion: The Current Device Landscape and Future Perspectives.

  2018cites this paper
• Long term outcomes after left atrial appendage closure with the LARIAT device—Stroke risk reduction over five years follow-up

  2018cites this paper
• Day‐case percutaneous left atrial appendage occlusion—Safety and efficacy

  2018cites this paper
• Left Atrial Appendages Occlusion: Current Status and Prospective

  2018cites this paper
• Left atrial appendage closure with the Ultraseal device: Initial experience and mid‐term follow‐up

  2018cites this paper
• Left atrial appendage occlusion for stroke prevention in diabetes mellitus patients with atrial fibrillation: Long‐term results

  2018cites this paper
• Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial

  2018cites this paper
• Transcatheter left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: results from the Belgian registry.

  2018cites this paper
• Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation

  2018cites this paper
• Left atrial appendage occlusion: 2016 in review.

  2017cites this paper
• Anesthetic Management of Patients Undergoing Percutaneous Endocardial and Epicardial Left Atrial Appendage Occlusion

  2017influential citation
• Percutaneous Left Atrial Appendage Closure: Current Devices and Clinical Outcomes

  2017cites this paper